Results 291 to 300 of about 591,821 (395)

Association of BMI with adherence and outcome in heart failure patients treated with wearable cardioverter defibrillator

ESC Heart Failure, Volume 12, Issue 2, Page 1295-1303, April 2025.
Abstract Background Obesity is a known risk factor for cardiovascular disease (CVD), yet an ‘obesity paradox’ has been observed in various CVD contexts. The impact of obesity on heart failure (HF) patients treated with a wearable cardioverter‐defibrillator (WCD) remains underexplored.
Mohammad Abumayyaleh, Katharina Koepsel, Julia W. Erath, Thomas Kuntz, Norbert Klein, Boldizsar Kovacs, Firat Duru, Ardan M. Saguner, Christian Blockhaus, Dong‐In Shin, Fabienne Kreimer, Michael Gotzmann, Hendrik Lapp, Thomas Beiert, Assem Aweimer, Andreas Mügge, Christel Weiß, Ibrahim El‐Battrawy, Ibrahim Akin   +18 more
wiley   +1 more source

Correction of Tricuspid Regurgitation in Pulmonary Arterial Hypertension. [PDF]

JACC Case Rep
Orlando A, Vergara A, Naeije R, D'Alto M.   +3 more
europepmc   +1 more source

Activated CD47 promotes pulmonary arterial hypertension through targeting caveolin-1 [PDF]

, 2012
Philip M. Bauer, Eileen Bauer, Natasha M. Rogers, Mingyi Yao, Mónica Feijoo‐Cuaresma, Joseph M. Pilewski, Hunter C. Champion, Brian S. Zuckerbraun, Marı́a J. Calzada, Jeffrey S. Isenberg   +9 more
openalex   +1 more source

Riociguat for the treatment of pulmonary arterial hypertension.

New England Journal of Medicine, 2013
H. Ghofrani, N. Galiè, F. Grimminger, E. Grünig, M. Humbert, Z. Jing, A. Keogh, D. Langleben, M. O. Kilama, A. Fritsch, D. Neuser, L. Rubin   +11 more
semanticscholar   +1 more source

Exercise limitations in amyloid cardiomyopathy assessed by cardiopulmonary exercise testing—A multicentre study

ESC Heart Failure, Volume 12, Issue 2, Page 1326-1335, April 2025.
Abstract Aims Amyloid cardiomyopathy is caused by the deposition of light chain (AL) or transthyretin amyloid (ATTR) fibrils, that leads to a restrictive cardiomyopathy, often resulting in heart failure (HF) with preserved or reduced ejection fraction.
Robin Willixhofer, Mauro Contini, Michele Emdin, Damiano Magrì, Alice Bonomi, Elisabetta Salvioni, Fabrizio Celeste, Alberico Del Torto, Claudio Passino, Christophe D.J. Capelle, Chiara Arzilli, Emiliano Fiori, Nicolò Capra, Christina Kronberger, Nikita Ermolaev, Andreas Kammerlander, Beatrice Musumeci, Giuseppe Vergaro, Vincenzo Castiglione, René Rettl, Giacomo Tini, Andrea Baggiano, Iacopo Fabiani, Susanna Sciomer, Roza Badr Eslam, Piergiuseppe Agostoni   +25 more
wiley   +1 more source

Lupus-Associated Pulmonary Arterial Hypertension: A Success Story. [PDF]

JACC Case Rep
Gregório C, Abrantes A, Cazeiro DI, Guimarães T, Fontes T, Dourado E, Pinto FJ, Plácido R.   +7 more
europepmc   +1 more source

Cardiogenic shock mortality according to Aetiology in a Mediterranean cohort: Results from the Shock‐CAT study

ESC Heart Failure, Volume 12, Issue 2, Page 1336-1345, April 2025.
Abstract Aims Mortality in cardiogenic shock (CS) remains elevated, with the potential for CS causes to impact prognosis and risk stratification. The aim was to investigate in‐hospital prognosis and mortality in CS patients according to aetiology. We also assessed the prognostic accuracy of CardShock and IABP‐SHOCK II scores.
Cosme García‐García, Teresa López‐Sobrino, Esther Sanz‐Girgas, Maria R. Cueto, Jaime Aboal, Pablo Pastor, Irene Buera, Alessandro Sionis, Rut Andrea, Judit Rodríguez‐López, Jose Carlos Sánchez‐Salado, Carlos Tomas, Jordi Bañeras, Albert Ariza, Josep Lupón, Antoni Bayés‐Genís, Ferran Rueda, Grup de Treball de Cures Agudes Cardiològiques Societat Catalana de Cardiologia   +17 more
wiley   +1 more source

Impact of Comorbidities on Treatments and Outcomes of Systemic Sclerosis-Associated Pulmonary Arterial Hypertension. [PDF]

Can Respir J
Lim L, Hansen D, Fairley J, Tabesh M, Ross L, Ferdowsi N, Ngian GS, Apostolopoulos D, Sahhar J, Host LV, Walker J, Major G, Proudman S, Stevens W, Nikpour M.   +14 more
europepmc   +1 more source

Transcatheter mitral valve replacement: when pulmonary arterial hypertension complicates prediction of neo-LVOT

Thomas Chollet, Thiziri Si Moussi, Sebastien Gonthier, Louis‐Marie Desroche   +3 more
openalex   +1 more source

Prognostic impact of iron deficiency in new‐onset chronic heart failure: Danish Heart Failure Registry insights

ESC Heart Failure, Volume 12, Issue 2, Page 1346-1357, April 2025.
Abstract Aims Iron deficiency (ID) is prevalent in chronic heart failure (HF) but lacks a consensus definition. This study evaluates the prevalence and the prognostic impact of ID using different criteria on all‐cause and cardiovascular mortality, as well as first hospitalization for HF in patients with new‐onset chronic HF.
Abdullahi Ahmed Mohamed, Daniel Mølager Christensen, Milan Mohammad, Christian Torp‐Pedersen, Lars Køber, Emil Loldrup Fosbøl, Tor Biering‐Sørensen, Morten Lock Hansen, Mariam Elmegaard Malik, Nina Nouhravesh, Charlotte Anderrson, Morten Schou, Gunnar Gislason   +12 more
wiley   +1 more source